Abstract
Recent studies underscore the need to target tumor progenitors that have been shown to be resistant to conventional chemotherapeutic agents. The present study was designed to discover novel compounds with activity against drug-resistant ovarian tumor-initiating cells (OTICs).
Original language | Chinese (Traditional) |
---|---|
Pages (from-to) | e132 |
Journal | Gynecologic Oncology |
Volume | 130 |
Issue number | 1 |
DOIs | |
Publication status | Published - Jul 2013 |
Externally published | Yes |